Publication:
Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19.

Thumbnail Image

Files

REPLY Biological Plausibility Behind J Am Coll Cardiol 2022.pdf (85.02 KB)
Identifiers
URI: http://hdl.handle.net/20.500.12105/15766
DOI: 10.1016/j.jacc.2021.10.030

Publication date

2022-01-04

Authors

Santos, Arnoldo

Advisors

Journal Title

Journal ISSN

Volume Title

Publishers

Elsevier
Metrics
Google Scholar
Export
MarcXML METS

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

MeSH Terms

COVID-19 Metoprolol Administration, Intravenous Adrenergic beta-1 Receptor Antagonists Humans SARS-CoV-2

DeCS Terms

Bibliographic citation

J Am Coll Cardiol. 2022 Jan 4;79(1):e13-e14

Collections

Grupos de investigación

Publisher version

10.1016/j.jacc.2021.10.030

Related dataset

Related publication

Document type

journal article